PSECX | VIVIX | PSECX / VIVIX | |
Total Expense Ratio | 2.03 | 0.04 | 5,075% |
Annual Report Gross Expense Ratio | 2.03 | 0.04 | 5,075% |
Fund Existence | 14 years | 27 years | - |
Gain YTD | 2.151 | 2.452 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 31.1M | 189B | 0% |
Annual Yield % from dividends | 0.47 | 2.29 | 20% |
Returns for 1 year | 8.29 | 8.01 | 103% |
Returns for 3 years | 21.84 | 32.19 | 68% |
Returns for 5 years | 48.36 | 72.56 | 67% |
Returns for 10 years | 49.13 | 103.54 | 47% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HWMAX | 51.84 | -0.38 | -0.73% |
Hotchkis & Wiley Mid-Cap Value A | |||
BVEIX | 20.77 | -0.20 | -0.95% |
Becker Value Equity Institutional | |||
RNWBX | 81.86 | -1.00 | -1.21% |
American Funds New World R2 | |||
DLCFX | 15.60 | -0.20 | -1.27% |
Destinations Large Cap Equity I | |||
LYRBX | 27.60 | -0.42 | -1.50% |
Lyrical US Value Equity Investor |